Article

High Doses of Painkillers Increase Stroke and Cardiac Risks

When taken in high doses, painkillers like Ibuprofen may increase the risk of heart attacks and strokes.

When taken in high doses, painkillers like Ibuprofen may increase the risk of heart attacks and strokes, according to a review published in the British Medical Journal.

The review, titled “Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis” was performed by researchers from Bern University in Switzerland.

The team analyzed a number of clinical trials, involving more than 116,000 patients. The goal was to report on the health effects of commonly used painkillers, such as NSAIDs, and anti-inflammatory drugs known as COX-2 inhibitors.

More specifically the team studied naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, and lumiracoxib.

The data demonstrated that the drugs carried risks that were not shown in placebo. For example, Rofecoxib and lumicoxib were associated with twice the risk of heart attack and ibuprofen demonstrated three times the risk of stroke. Four-times the risk of cardiovascular death was associated with Arcoxia and the generic drug diclofenac. Naproxen was shown to be the safest pain killer for those with osteoarthritis, in terms of stroke and cardiac risks.

Around the web:

Painkillers 'link' to heart attacks

http://hcp.lv/f5zcTG

Analysis shows heart, stroke risk of pain drugs

http://hcp.lv/ifrU0i

NSAID painkillers linked to increased heart risk

http://hcp.lv/ijZYxq

Generic Painkillers May Increase Risk of Heart Attack, Stroke, Review Says

http://hcp.lv/e83e7M

Popular painkillers can increase heart attack risks, study shows

http://hcp.lv/ecZjvE

Pain Medication Complications Video

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.